Peter Holme Jensen
Directeur/Bestuurslid bij AQUAPORIN A/S
Vermogen: 670 560 $ op 30-04-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Niels Thomas Heering | M | 69 |
Aquaporin Space Alliance ApS
 Aquaporin Space Alliance ApS Aerospace & DefenseElectronic Technology Aquaporin Space Alliance ApS operates as joint venture that commercializes the Aquaporin Inside technology in space applications and space programs together with European and US-based entities. The firm develops water recycling and filtration solutions. The company was founded in May 2013 and is headquartered in Odense, Denmark. | 9 jaar |
| Anne Broeng | F | 62 | 6 jaar | |
| Matt Boczkowski | M | 46 | 3 jaar | |
| Sven-Erik Lennart Nilsson | M | 83 |
ENKAM Pharmaceuticals A/S
 ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | 23 jaar |
| Søren Bjørn Hansen | M | 52 |
Aquaporin Space Alliance ApS
Aquaporin Space Alliance ApS Aerospace & DefenseElectronic Technology Aquaporin Space Alliance ApS operates as joint venture that commercializes the Aquaporin Inside technology in space applications and space programs together with European and US-based entities. The firm develops water recycling and filtration solutions. The company was founded in May 2013 and is headquartered in Odense, Denmark. | 17 jaar |
| Torsten Hoybye Regueira | M | - | - | |
| Klaus Wulff | M | 51 | 2 jaar | |
| Anupam Bhargava | M | 57 | 3 jaar | |
| Lars Hansen | M | 57 | 17 jaar | |
| Thomas Axel Esbern Andersen | M | - |
Aquaporin Space Alliance ApS
Aquaporin Space Alliance ApS Aerospace & DefenseElectronic Technology Aquaporin Space Alliance ApS operates as joint venture that commercializes the Aquaporin Inside technology in space applications and space programs together with European and US-based entities. The firm develops water recycling and filtration solutions. The company was founded in May 2013 and is headquartered in Odense, Denmark. | 11 jaar |
| Wei Ming Jiang | M | 68 | 6 jaar | |
| Annemarie Munk Riis | F | - |
InnovationsFonden
 InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | - |
| Jian Long Zhuang | M | 60 | 3 jaar | |
| Mads Andersen | M | - |
InnovationsFonden
InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | 4 jaar |
| Lars Frølund | M | - |
InnovationsFonden
InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | 5 jaar |
| Charlotte Rønhof | F | - |
InnovationsFonden
InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | 2 jaar |
| Christian H. M. Ketels | M | - |
InnovationsFonden
InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | 4 jaar |
| Joerg Hess | M | 57 | 5 jaar | |
| Mette Glavind | F | - |
InnovationsFonden
InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | 4 jaar |
| Henrik Jørgen Andersen | M | 64 |
InnovationsFonden
InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | 4 jaar |
| Camilla Haustrup Hermansen | F | - |
InnovationsFonden
InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | 4 jaar |
| Anders Eldrup | M | 76 |
InnovationsFonden
InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | - |
| Jon Jensen | M | - | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Jens Denkov | M | 43 | 3 jaar | |
| Torsten Freltoft | M | 66 | - | |
| Jan-Eric Österlund | M | 79 |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | 15 jaar |
| Morten Østergaard Jensen | M | - | - | |
| Jens Frederik Lage Hansen | M | - | - | |
| Morten Albrechtsen | M | 60 |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | 18 jaar |
| Michael Frank | M | 61 | - | |
| Jian Wen Cai | M | 50 | 7 jaar | |
| Volodymyr Berezin | M | - |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | 9 jaar |
| Marianne Olsen | F | - |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
| Flemming Martin Poulsen | M | - |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
| Arne Valdemar Holm | M | - |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
| Vladyslav Soroka | M | - |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
| Lars Christian Rønn | M | - |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
| Elisabeth Marianne Bock | F | - |
ENKAM Pharmaceuticals A/S
ENKAM Pharmaceuticals A/S Medical SpecialtiesHealth Technology ENKAM Pharmaceuticals A/S develops new drugs for treatment of primary neurological diseases. It focuses on properties that target the Neural Cell Adhesion Molecule/Fibroblast Growth Factor receptor for treatment of Central Nervous System disorders. The company was founded by Peter Holme Jensen, Volodymyr Berezin, Marianne Olsen, Flemming Martin Poulsen, Arne Valdemar Holm. Vladyslav Soroka, Lars Christian Biilmann Rønn, and Elisabeth Marianne Bock on December 12, 2000 and is headquartered in Copenhagen, Denmark. | - |
| Bo Karmark | M | 58 | 7 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Denemarken | 39 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Peter Holme Jensen
- Persoonlijk netwerk